Innovative Antiviral Therapies
The program area Innovative Antiviral Therapies focuses on translational research. The aim is to identify new approaches for the development of antiviral agents and tumor therapy.
The Innovative Antiviral Therapies program area focuses on translational research to validate antiviral targets and experimental therapies. The Next Generation Sequencing and Small Animal Models technology platforms support the in vitro and in vivo evaluation of new antiviral therapies.
Contact
Head of Research Group
Phone: +49 (0)40 48051-245
Email: Please enable JavaScript to render this link!